Literature DB >> 14674238

PTEN and myotubularins: families of phosphoinositide phosphatases.

Gregory S Taylor1, Jack E Dixon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674238     DOI: 10.1016/s0076-6879(03)66004-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  17 in total

1.  Myotubularin-related protein (MTMR) 9 determines the enzymatic activity, substrate specificity, and role in autophagy of MTMR8.

Authors:  Jun Zou; Chunfen Zhang; Jasna Marjanovic; Marina V Kisseleva; Philip W Majerus; Monita P Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

2.  Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.

Authors:  Shekhar Srivastava; Kyung Ko; Papiya Choudhury; Zhai Li; Amanda K Johnson; Vivek Nadkarni; Derya Unutmaz; William A Coetzee; Edward Y Skolnik
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

3.  Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane.

Authors:  Francisca Vazquez; Satomi Matsuoka; William R Sellers; Toshio Yanagida; Masahiro Ueda; Peter N Devreotes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

4.  Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers.

Authors:  Nilanjana Chatterjee; Evangelos Pazarentzos; Manasi K Mayekar; Philippe Gui; David V Allegakoen; Gorjan Hrustanovic; Victor Olivas; Luping Lin; Erik Verschueren; Jeffrey R Johnson; Matan Hofree; Jenny J Yan; Billy W Newton; John V Dollen; Charles H Earnshaw; Jennifer Flanagan; Elton Chan; Saurabh Asthana; Trey Ideker; Wei Wu; Junji Suzuki; Benjamin A Barad; Yuriy Kirichok; James S Fraser; William A Weiss; Nevan J Krogan; Asmin Tulpule; Amit J Sabnis; Trever G Bivona
Journal:  Cell Rep       Date:  2019-08-27       Impact factor: 9.423

5.  Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.

Authors:  Shekhar Srivastava; Papiya Choudhury; Zhai Li; Gongxin Liu; Vivek Nadkarni; Kyung Ko; William A Coetzee; Edward Y Skolnik
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

6.  Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice.

Authors:  Fred L Robinson; Ingrid R Niesman; Kristina K Beiswenger; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-18       Impact factor: 11.205

7.  Imaging and manipulating phosphoinositides in living cells.

Authors:  Tamas Balla
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

8.  The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies.

Authors:  Barbara Royer; Karim Hnia; Christos Gavriilidis; Hélène Tronchère; Valérie Tosch; Jocelyn Laporte
Journal:  EMBO Rep       Date:  2013-08-06       Impact factor: 8.807

9.  Live cell imaging of phosphoinositides with expressed inositide binding protein domains.

Authors:  Péter Várnai; Tamas Balla
Journal:  Methods       Date:  2008-10-16       Impact factor: 3.608

10.  MTMR9 increases MTMR6 enzyme activity, stability, and role in apoptosis.

Authors:  Jun Zou; Shao-Chun Chang; Jasna Marjanovic; Philip W Majerus
Journal:  J Biol Chem       Date:  2008-11-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.